Literature DB >> 27074135

Synthesis of Azepane Derivatives by Silyl-aza-Prins Cyclization of Allylsilyl Amines: Influence of the Catalyst in the Outcome of the Reaction.

Asunción Barbero1, Alberto Diez-Varga1, Francisco J Pulido1, Alfonso González-Ortega1.   

Abstract

The synthesis of seven-membered nitrogen heterocycles by silyl-aza-Prins cyclization is described. The process provides trans-azepanes in high yields and good to excellent diastereoselectivities. Moreover, the reaction outcome is dependent on the Lewis acid employed. Thus, while azepanes are selectively obtained when InCl3 is used, the reaction in the presence of TMSOTf provides tetrahydropyran derivatives corresponding to a tandem Sakurai-Prins cyclization.

Entities:  

Year:  2016        PMID: 27074135     DOI: 10.1021/acs.orglett.6b00538

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Employing of Fe3O4/CuO/ZnO@MWCNT MNCs in the solvent-free synthesis of new cyanopyrroloazepine derivatives and investigation of biological activity.

Authors:  Neda Zare Davijani; Reza Kia-Kojoori; Shahrzad Abdolmohammadi; Sepehr Sadegh-Samiei
Journal:  Mol Divers       Date:  2021-12-03       Impact factor: 3.364

2.  Influence of the Substituents on the Opening of Silylepoxy Alcohols: 5-exo-Cyclization towards Tetrahydrofurans vs. Unexpected Side Reaction Leading to Tetrahydropyrans.

Authors:  Carlos Díez-Poza; Asunción Barbero
Journal:  Molecules       Date:  2021-12-06       Impact factor: 4.411

3.  Synthesis of Tetrahydroazepines through Silyl Aza-Prins Cyclization Mediated by Iron(III) Salts.

Authors:  Victoria Sinka; Israel Fernández; Juan I Padrón
Journal:  J Org Chem       Date:  2022-08-17       Impact factor: 4.198

4.  Synthesis of Functionalized Azepines via Cu(I)-Catalyzed Tandem Amination/Cyclization Reaction of Fluorinated Allenynes.

Authors:  Anna N Philippova; Daria V Vorobyeva; Pavel S Gribanov; Ivan A Godovikov; Sergey N Osipov
Journal:  Molecules       Date:  2022-08-15       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.